Diclofenac and its transformation products: Environmental occurrence and toxicity - A review

Environment International

Volumn 96, Issue , 2016, Pages 127-138

  Lonappan, Linson ^a   Brar, Satinder Kaur ^a   Das, Ratul Kumar ^a   Verma, Mausam ^b   Surampalli, Rao Y ^c  

^a CENTRE EAU TERRE ENVIRONNEMENT   (Canada)

^b CO2 Solutions Inc ^*  (Canada)

^c UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

Diclofenac; Emerging contaminant; Environmental fate; Interactions; Metabolites; Toxicity

Indexed keywords

BEAM PLASMA INTERACTIONS; BIOMOLECULES; CONTAMINATION; METABOLITES; SEWAGE PUMPING PLANTS; SURFACE WATERS; TOXICITY; WASTEWATER TREATMENT; WATER TREATMENT PLANTS;

DICLOFENAC; EMERGING CONTAMINANT; ENVIRONMENTAL COMPARTMENT; ENVIRONMENTAL CONCENTRATION; ENVIRONMENTAL CONTAMINANT; ENVIRONMENTAL FATE; ENVIRONMENTAL OCCURRENCE; WASTEWATER TREATMENT PLANTS;

SEWAGE TREATMENT PLANTS;

1 O ACYL GLUCURONIDE; 3' HYDROXY 4' METHOXY DICLOFENAC; 3' HYDROXYDICLOFENAC; 3' HYDROXYDICLOFENAC [2 (2,6 DICHLORO 3 HYDROXYPHENYLAMINO)PHENYLETHANOIC ACID]; 4' HYDROXY DICLOFENAC; 4' HYDROXYDICLOFENAC; 4' HYDROXYDICLOFENAC [2 (2,6 DICHLORO 4 HYDROXYPHENYLAMINO)PHENYLETHANOIC ACID]; 4',5 DIHYDROXYDICLOFENAC; 4'5 DIHYDROXYDICLOFENAC [2 (2,6 DICHLORO 4 HYDROXYPHENYLAMINO) 5 HYDROXYPHENYLETHANOIC ACID]; 5' HYDROXYDICLOFENAC; 5' HYDROXYDICLOFENAC [2 (2,6 DICHLOROPHENYLAMINO) 5 HYDROXYPHENYLETHANOIC ACID]; CARBOHYDRATE; CARBON; DICLOFENAC; DISSOLVED ORGANIC MATTER; DRUG METABOLITE; FAT; HEAVY METAL; INORGANIC COMPOUND; LEAD; MERCURY; NITROGEN; ORGANIC COMPOUND; PESTICIDE; PHENOL DERIVATIVE; PHOSPHORUS; PROTEIN; SURFACTANT; UNCLASSIFIED DRUG; UNINDEXED DRUG; WATER;

DRUG; ENVIRONMENTAL FATE; FRESHWATER ECOSYSTEM; METABOLITE; POLLUTANT; TOXICITY; WATER TREATMENT;

AQUATIC ENVIRONMENT; BIODEGRADATION; CHEMICAL INTERACTION; ECOTOXICITY; ENVIRONMENTAL IMPACT; ENVIRONMENTAL IMPACT ASSESSMENT; HUMAN; LAW; NO-OBSERVED-ADVERSE-EFFECT CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SOIL POLLUTION; TERRESTRIAL SPECIES; WASTE COMPONENT REMOVAL; WASTE WATER TREATMENT PLANT; WATER CONTAMINATION; ANIMAL; ENVIRONMENT; LEGISLATION AND JURISPRUDENCE; POLLUTION; WASTE WATER; WATER POLLUTANT;

ANIMALS; DICLOFENAC; ENVIRONMENT; ENVIRONMENTAL POLLUTION; HUMANS; WASTE WATER; WATER POLLUTANTS, CHEMICAL;

EID: 84987984665     PISSN: 01604120     EISSN: 18736750     Source Type: Journal    
DOI: 10.1016/j.envint.2016.09.014     Document Type: Review

References (138)

1. Acuña, V., Ginebreda, A., Mor, J.R., Petrovic, M., Sabater, S., Sumpter, J., Barceló, D., Balancing the health benefits and environmental risks of pharmaceuticals: diclofenac as an example. Environ. Int. 85 (2015), 327–333.
2. Agüera, A., Pérez Estrada, L.A., Ferrer, I., Thurman, E.M., Malato, S., Fernández-Alba, A.R., Application of time-of-flight mass spectrometry to the analysis of phototransformation products of diclofenac in water under natural sunlight. J. Mass Spectrom. 40 (2005), 908–915.
3. Ahrer, W., Scherwenk, E., Buchberger, W., Determination of drug residues in water by the combination of liquid chromatography or capillary electrophoresis with electrospray mass spectrometry. J. Chromatogr. A 910 (2001), 69–78.
4. Alder, A.C., Bruchet, A., Carballa, M., Clara, M., Joss, A., Löffler, D., McArdell, C.S., Miksch, K., Omil, F., Tuhkanen, T., Ternes, T.A., Consumption and occurrence. T.A., T., A., J., (eds.) Human Pharmaceuticals, Hormones and Fragrances. The Challenge of Micropollutants in Urban Water Management, 2006, IWA Publishing.
5. Al-Rajab, A.J., Sabourin, L., Lapen, D.R., Topp, E., The non-steroidal anti-inflammatory drug diclofenac is readily biodegradable in agricultural soils. Sci. Total Environ. 409 (2010), 78–82.
6. Anumol, T., Vijayanandan, A., Park, M., Philip, L., Snyder, S.A., Occurrence and fate of emerging trace organic chemicals in wastewater plants in Chennai, India. Environ. Int. 92–93 (2016), 33–42.
7. Aristi, I., Casellas, M., Elosegi, A., Insa, S., Petrovic, M., Sabater, S., Acuña, V., Nutrients versus emerging contaminants–or a dynamic match between subsidy and stress effects on stream biofilms. Environ. Pollut. 212 (2016), 208–215.
8. Backhaus, T., Medicines, shaken and stirred: a critical review on the ecotoxicology of pharmaceutical mixtures. Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci., 2014, 369.
9. Barakat, M.A., New trends in removing heavy metals from industrial wastewater. Arab. J. Chem. 4 (2011), 361–377.
10. Behera, S.K., Kim, H.W., Oh, J.-E., Park, H.-S., Occurrence and removal of antibiotics, hormones and several other pharmaceuticals in wastewater treatment plants of the largest industrial city of Korea. Sci. Total Environ. 409 (2011), 4351–4360.
11. Beltran, F.J., Pocostales, P., Alvarez, P., Oropesa, A., Diclofenac removal from water with ozone and activated carbon. J. Hazard. Mater. 163 (2009), 768–776.
12. Bendz, D., Paxeus, N.A., Ginn, T.R., Loge, F.J., Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Hoje River in Sweden. J. Hazard. Mater. 122 (2005), 195–204.
13. Benotti, M.J., Trenholm, R.A., Vanderford, B.J., Holady, J.C., Stanford, B.D., Snyder, S.A., Pharmaceuticals and endocrine disrupting compounds in U.S. drinking water. Environ. Sci. Technol. 43 (2008), 597–603.
14. BirdLife, I., Vultures are under threat from the veterinary drug diclofenac. Presented as part of the BirdLife State of the world's birds website, 2013.
15. Boettcher, I.W., Pfeilschifter, J., Schweizer, A., Sallmann, A., Wenk, P., Pharmacological properties of five diclofenac metabolites identified in human plasma. Agents Actions 34 (1991), 135–137.
16. Buser, H.-R., Poiger, T., Müller, M.D., Occurrence and fate of the pharmaceutical drug diclofenac in surface waters: rapid photodegradation in a Lake. Environ. Sci. Technol. 32 (1998), 3449–3456.
17. Carballa, M., Omil, F., Lema, J.M., Removal of cosmetic ingredients and pharmaceuticals in sewage primary treatment. Water Res. 39 (2005), 4790–4796.
18. Carmona, E., Andreu, V., Picó, Y., Occurrence of acidic pharmaceuticals and personal care products in Turia River Basin: from waste to drinking water. Sci. Total Environ. 484 (2014), 53–63.
19. Carter, L.J., Garman, C.D., Ryan, J., Dowle, A., Bergstrom, E., Thomas-Oates, J., Boxall, A.B., Fate and uptake of pharmaceuticals in soil-earthworm systems. Environ. Sci. Technol. 48 (2014), 5955–5963.
20. Carter, L.J., Harris, E., Williams, M., Ryan, J.J., Kookana, R.S., Boxall, A.B., Fate and uptake of pharmaceuticals in soil-plant systems. J. Agric. Food Chem. 62 (2014), 816–825.
21. Chefetz, B., Mualem, T., Ben-Ari, J., Sorption and mobility of pharmaceutical compounds in soil irrigated with reclaimed wastewater. Chemosphere 73 (2008), 1335–1343.
22. Clara, M., Strenn, B., Gans, O., Martinez, E., Kreuzinger, N., Kroiss, H., Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants. Water Res. 39 (2005), 4797–4807.
23. Cleuvers, M., Aquatic ecotoxicity of pharmaceuticals including the assessment of combination effects. Toxicol. Lett. 142 (2003), 185–194.
24. Cleuvers, M., Mixture toxicity of the anti-inflammatory drugs diclofenac, ibuprofen, naproxen, and acetylsalicylic acid. Ecotoxicol. Environ. Saf. 59 (2004), 309–315.
25. Cleuvers, M., Chronic mixture toxicity of pharmaceuticals to daphnia – the example of nonsteroidal anti-inflammatory drugs. Kümmerer, K., (eds.) Pharmaceuticals in the Environment: Sources, Fate, Effects and Risks, 2008, Springer Berlin Heidelberg, Berlin, Heidelberg, 277–284.
26. da Silva Oliveira, A., Bocio, A., Beltramini Trevilato, T.M., Magosso Takayanagui, A.M., Domingo, J.L., Segura-Muñoz, S.I., Heavy metals in untreated/treated urban effluent and sludge from a biological wastewater treatment plant. Environ. Sci. Pollut. Res. Int. 14 (2007), 483–489.
27. Dai, G., Wang, B., Huang, J., Dong, R., Deng, S., Yu, G., Occurrence and source apportionment of pharmaceuticals and personal care products in the Beiyun River of Beijing, China. Chemosphere 119 (2015), 1033–1039.
28. Das, D., Cuthbert, R.J., Jakati, R.D., Prakash, V., Diclofenac is toxic to the Himalayan vulture Gyps himalayensis. Bird Conserv. Int. 21 (2010), 72–75.
29. Drillia, P., Stamatelatou, K., Lyberatos, G., Fate and mobility of pharmaceuticals in solid matrices. Chemosphere 60 (2005), 1034–1044.
30. Ericson, H., Thorsen, G., Kumblad, L., Physiological effects of diclofenac, ibuprofen and propranolol on Baltic Sea blue mussels. Aquat. Toxicol. 99 (2010), 223–231.
31. Eriksson, J., Svanfelt, J., Kronberg, L., A photochemical study of diclofenac and its major transformation products. Photochem. Photobiol. 86 (2010), 528–532.
32. Fatta-Kassinos, D., Hapeshi, E., Achilleos, A., Meric, S., Gros, M., Petrovic, M., Barcelo, D., Existence of pharmaceutical compounds in tertiary treated urban wastewater that is utilized for reuse applications. Water Resour. Manag. 25 (2011), 1183–1193.
33. Fent, K., Weston, A.A., Caminada, D., Ecotoxicology of human pharmaceuticals. Aquat. Toxicol. 76 (2006), 122–159.
34. Ferrari, B.t., Paxéus, N., Giudice, R.L., Pollio, A., Garric, J., Ecotoxicological impact of pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid, and diclofenac. Ecotoxicol. Environ. Saf. 55 (2003), 359–370.
35. Ferrari, B., Mons, R., Vollat, B., Fraysse, B., Paxēaus, N., Giudice, R.L., Pollio, A., Garric, J., Environmental risk assessment of six human pharmaceuticals: are the current environmental risk assessment procedures sufficient for the protection of the aquatic environment?. Environ. Toxicol. Chem. 23 (2004), 1344–1354.
36. Gomez, M.J., Martinez Bueno, M.J., Lacorte, S., Fernandez-Alba, A.R., Aguera, A., Pilot survey monitoring pharmaceuticals and related compounds in a sewage treatment plant located on the Mediterranean coast. Chemosphere 66 (2007), 993–1002.
37. Gonzalez-Rey, M., Bebianno, M.J., Effects of non-steroidal anti-inflammatory drug (NSAID) diclofenac exposure in mussel Mytilus galloprovincialis. Aquat. Toxicol. 148 (2014), 221–230.
38. Gros, M., Petrovic, M., Ginebreda, A., Barcelo, D., Removal of pharmaceuticals during wastewater treatment and environmental risk assessment using hazard indexes. Environ. Int. 36 (2010), 15–26.
39. Haap, T., Triebskorn, R., Kohler, H.R., Acute effects of diclofenac and DMSO to Daphnia magna: immobilisation and hsp70-induction. Chemosphere 73 (2008), 353–359.
40. Hallare, A.V., Kohler, H.R., Triebskorn, R., Developmental toxicity and stress protein responses in zebrafish embryos after exposure to diclofenac and its solvent, DMSO. Chemosphere 56 (2004), 659–666.
41. Halling-Sørensen, B., Nors Nielsen, S., Lanzky, P.F., Ingerslev, F., Holten Lützhøft, H.C., Jørgensen, S.E., Occurrence, fate and effects of pharmaceutical substances in the environment - a review. Chemosphere 36 (1998), 357–393.
42. Hao, C., Clement, R., Yang, P., Liquid chromatography–tandem mass spectrometry of bioactive pharmaceutical compounds in the aquatic environment—a decade's activities. Anal. Bioanal. Chem. 387 (2007), 1247–1257.
43. Heberer, T., Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. Toxicol. Lett. 131 (2002), 5–17.
44. Heberer, T., Tracking persistent pharmaceutical residues from municipal sewage to drinking water. J. Hydrol. 266 (2002), 175–189.
45. Heberer, T., Schmidt-Baumler, K., Stan, H.J., Occurrence and distribution of organic contaminants in the aquatic system in Berlin. Part I: Drug residues and other polar contaminants in Berlin surface and groundwater. Acta Hydrochim. Hydrobiol. 26 (1998), 272–278.
46. Henry, D., M., O.′.R., (eds.) Widely Used Diclofenac Associated With Increased Risk for Cardiovascular Events, 2013, Heartwire, Toronto www.medscape.com.
47. Hernando, M.D., Mezcua, M., Fernández-Alba, A.R., Barceló, D., Environmental risk assessment of pharmaceutical residues in wastewater effluents, surface waters and sediments. Talanta 69 (2006), 334–342.
48. Hilton, M.J., Thomas, K.V., Determination of selected human pharmaceutical compounds in effluent and surface water samples by high-performance liquid chromatography–electrospray tandem mass spectrometry. J. Chromatogr. A 1015 (2003), 129–141.
49. Hoeger, B., Kollner, B., Dietrich, D.R., Hitzfeld, B., Water-borne diclofenac affects kidney and gill integrity and selected immune parameters in brown trout (Salmo trutta f. fario). Aquat. Toxicol. 75 (2005), 53–64.
50. Hoeger, B., Dietrich, D.R., Schmid, D., Hartmann, A., Hitzfeld, B., Distribution of intraperitoneally injected diclofenac in brown trout (Salmo trutta f. fario). Ecotoxicol. Environ. Saf. 71 (2008), 412–418.
51. Huschek, G., Hansen, P.D., Maurer, H.H., Krengel, D., Kayser, A., Environmental risk assessment of medicinal products for human use according to European Commission recommendations. Environ. Toxicol. 19 (2004), 226–240.
52. Johnson, A.C., Dumont, E., Williams, R.J., Oldenkamp, R., Cisowska, I., Sumpter, J.P., Do concentrations of ethinylestradiol, estradiol, and diclofenac in European rivers exceed proposed EU environmental quality standards?. Environ. Sci. Technol. 47 (2013), 12297–12304.
53. Jones, O.A., Voulvoulis, N., Lester, J.N., Aquatic environmental assessment of the top 25 English prescription pharmaceuticals. Water Res. 36 (2002), 5013–5022.
54. Kallio, J.-M., Lahti, M., Oikari, A., Kronberg, L., Metabolites of the aquatic pollutant diclofenac in fish bile. Environ. Sci. Technol. 44 (2010), 7213–7219.
55. Karvelas, M., Katsoyiannis, A., Samara, C., Occurrence and fate of heavy metals in the wastewater treatment process. Chemosphere 53 (2003), 1201–1210.
56. Kasprzyk-Hordern, B., Dinsdale, R.M., Guwy, A.J., The occurrence of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs in surface water in South Wales, UK. Water Res. 42 (2008), 3498–3518.
57. Khadka, K.K., Mandal, R.K., Understanding the efficacy of diclofenac use-ban and its aftermath effect on Gyps vulture in Koshi Tappu Wildlife Reserve, Nepal. J. Entomol. Zool. 1 (2013), 20–22.
58. Khan, S.J., Ongerth, J.E., Modelling of pharmaceutical residues in Australian sewage by quantities of use and fugacity calculations. Chemosphere 54 (2004), 355–367.
59. Khetan, S.K., Collins, T.J., Human pharmaceuticals in the aquatic environment: a challenge to green chemistry. Chem. Rev. 107 (2007), 2319–2364.
60. Kim, S.D., Cho, J., Kim, I.S., Vanderford, B.J., Snyder, S.A., Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and waste waters. Water Res. 41 (2007), 1013–1021.
61. Kimura, K., Hara, H., Watanabe, Y., Removal of pharmaceutical compounds by submerged membrane bioreactors (MBRs). Desalination 178 (2005), 135–140.
62. Kosjek, T., Heath, E., Krbavcic, A., Determination of non-steroidal anti-inflammatory drug (NSAIDs) residues in water samples. Environ. Int. 31 (2005), 679–685.
63. Kovala-Demertzi, D., Transition metal complexes of diclofenac with potentially interesting anti-inflammatory activity. J. Inorg. Biochem. 79 (2000), 153–157.
64. Kummerer, K., Pharmaceuticals in the environment – a brief summary. K., K., (eds.) Pharmaceuticals in the Environment, 2004, Springer-Verlag, Heidelberg, Berlin.
65. Kunkel, U., Radke, M., Fate of pharmaceuticals in rivers: deriving a benchmark dataset at favorable attenuation conditions. Water Res. 46 (2012), 5551–5565.
66. Langford, K.H., Reid, M., Thomas, K.V., Multi-residue screening of prioritised human pharmaceuticals, illicit drugs and bactericides in sediments and sludge. J. Environ. Monit. 13 (2011), 2284–2291.
67. Larsson, E., Rabayah, A., Jonsson, J.K., Sludge removal of nonsteroidal anti-inflammatory drugs during wastewater treatment studied by direct hollow fiber liquid phase microextraction. J. Environ. Prot., Vol. 04(No. 09), 2013, 10.
68. Lawrence, J.R., SWERHONE, G.D.W., TOPP, E., KORBER, D.R., NEU, T.R., WASSENAAR, L.I., Structural and functional responses of river biofilm communities to the nonsteroidal anti-inflammatory diclofenac. Environ. Toxicol. Chem. 26 (2007), 573–582.
69. Lee, J., Ji, K., Lim Kho, Y., Kim, P., Choi, K., Chronic exposure to diclofenac on two freshwater cladocerans and Japanese medaka. Ecotoxicol. Environ. Saf. 74 (2011), 1216–1225.
70. Letzel, M., Metzner, G., Letzel, T., Exposure assessment of the pharmaceutical diclofenac based on long-term measurements of the aquatic input. Environ. Int. 35 (2009), 363–368.
71. Lindqvist, N., Tuhkanen, T., Kronberg, L., Occurrence of acidic pharmaceuticals in raw and treated sewages and in receiving waters. Water Res. 39 (2005), 2219–2228.
72. Lonappan, L., Pulicharla, R., Rouissi, T., Brar, S.K., Verma, M., Surampalli, R.Y., Valero, J.R., Diclofenac in municipal wastewater treatment plant: quantification using laser diode thermal desorption—atmospheric pressure chemical ionization—tandem mass spectrometry approach in comparison with an established liquid chromatography-electrospray ionization–tandem mass spectrometry method. J. Chromatogr. A 1433 (2016), 106–113.
73. Loos, R., Locoro, G., Comero, S., Contini, S., Schwesig, D., Werres, F., Balsaa, P., Gans, O., Weiss, S., Blaha, L., Bolchi, M., Gawlik, B.M., Pan-European survey on the occurrence of selected polar organic persistent pollutants in ground water. Water Res. 44 (2010), 4115–4126.
74. López-Serna, R., Petrović, M., Barceló, D., Occurrence and distribution of multi-class pharmaceuticals and their active metabolites and transformation products in the Ebro River basin (NE Spain). Sci. Total Environ. 440 (2012), 280–289.
75. Lopez-Serna, R., Jurado, A., Vazquez-Sune, E., Carrera, J., Petrovic, M., Barcelo, D., Occurrence of 95 pharmaceuticals and transformation products in urban groundwaters underlying the metropolis of Barcelona, Spain. Environ. Pollut. 174 (2013), 305–315.
76. Ma, R., Wang, B., Lu, S., Zhang, Y., Yin, L., Huang, J., Deng, S., Wang, Y., Yu, G., Characterization of pharmaceutically active compounds in Dongting Lake, China: occurrence, chiral profiling and environmental risk. Sci. Total Environ. 557–558 (2016), 268–275.
77. Marco-Urrea, E., Pérez-Trujillo, M., Cruz-Morató, C., Caminal, G., Vicent, T., Degradation of the drug sodium diclofenac by Trametes versicolor pellets and identification of some intermediates by NMR. J. Hazard. Mater. 176 (2010), 836–842.
78. Markandya, A., Taylor, T., Longo, A., Murty, M.N., Murty, S., Dhavala, K., Counting the cost of vulture decline—an appraisal of the human health and other benefits of vultures in India. Ecol. Econ. 67 (2008), 194–204.
79. Martín, J., Camacho-Muñoz, D., Santos, J.L., Aparicio, I., Alonso, E., Occurrence of pharmaceutical compounds in wastewater and sludge from wastewater treatment plants: removal and ecotoxicological impact of wastewater discharges and sludge disposal. J. Hazard. Mater. 239–240 (2012), 40–47.
80. McGettigan, P., Henry, D., Use of non-steroidal anti-inflammatory drugs that elevate cardiovascular risk: an examination of sales and essential medicines lists in low-, middle-, and high-income countries. PLoS Med., 10, 2013, e1001388.
81. Mehinto, A.C., Hill, E.M., Tyler, C.R., Uptake and biological effects of environmentally relevant concentrations of the nonsteroidal anti-inflammatory pharmaceutical diclofenac in rainbow trout (Oncorhynchus mykiss). Environ. Sci. Technol. 44 (2010), 2176–2182.
82. Memmert, U., Peither, A., Burri, R., Weber, K., Schmidt, T., Sumpter, J.P., Hartmann, A., Diclofenac: new data on chronic toxicity and bioconcentration in fish. Environ. Toxicol. Chem. 32 (2013), 442–452.
83. Metcalfe, C.D., Miao, X.-S., Koenig, B.G., Struger, J., Distribution of acidic and neutral drugs in surface waters near sewage treatment plants in the lower great lakes, Canada. Environ. Toxicol. Chem. 22 (2003), 2881–2889.
84. Moore, D.E., Roberts-Thomson, S., Zhen, D., Duke, C.C., Photochemical studies on the antiinflammatory drug diclofenac. Photochem. Photobiol. 52 (1990), 685–690.
85. Naidoo, V., Swan, G.E., Diclofenac toxicity in Gyps vulture is associated with decreased uric acid excretion and not renal portal vasoconstriction. Comp. Biochem. Physiol., Part C: Toxicol. Pharmacol. 149 (2009), 269–274.
86. Naidoo, V., Wolter, K., Cuthbert, R., Duncan, N., Veterinary diclofenac threatens Africa's endangered vulture species. Regul. Toxicol. Pharmacol. 53 (2009), 205–208.
87. Naisbitt, D.J., Sanderson, L.S., Meng, X., Stachulski, A.V., Clarke, S.E., Park, B.K., Investigation of the immunogenicity of diclofenac and diclofenac metabolites. Toxicol. Lett. 168 (2007), 45–50.
88. Oaks, J.L., Gilbert, M., Virani, M.Z., Watson, R.T., Meteyer, C.U., Rideout, B.A., Shivaprasad, H.L., Ahmed, S., Iqbal Chaudhry, M.J., Arshad, M., Mahmood, S., Ali, A., Ahmed Khan, A., Diclofenac residues as the cause of vulture population decline in Pakistan. Nature 427 (2004), 630–633.
89. Öllers, S., Singer, H.P., Fässler, P., Müller, S.R., Simultaneous quantification of neutral and acidic pharmaceuticals and pesticides at the low-ng/l level in surface and waste water. J. Chromatogr. A 911 (2001), 225–234.
90. Osorio, V., Sanchís, J., Abad, J.L., Ginebreda, A., Farré, M., Pérez, S., Barceló, D., Investigating the formation and toxicity of nitrogen transformation products of diclofenac and sulfamethoxazole in wastewater treatment plants. J. Hazard. Mater. 309 (2016), 157–164.
91. Palmer, E., Top 20 generic molecules worldwide. wwwfiercepharmacom, 2012.
92. Pereira, A.M.P.T., Silva, L.J.G., Meisel, L.M., Lino, C.M., Pena, A., Environmental impact of pharmaceuticals from Portuguese wastewaters: geographical and seasonal occurrence, removal and risk assessment. Environ. Res. 136 (2015), 108–119.
93. Pereira, C.D.S., Maranho, L.A., Cortez, F.S., Pusceddu, F.H., Santos, A.R., Ribeiro, D.A., Cesar, A., Guimarães, L.L., Occurrence of pharmaceuticals and cocaine in a Brazilian coastal zone. Sci. Total Environ. 548–549 (2016), 148–154.
94. Petrović, M., Gonzalez, S., Barceló, D., Analysis and removal of emerging contaminants in wastewater and drinking water. TrAC Trends Anal. Chem. 22 (2003), 685–696.
95. Prakash, V., Pain, D.J., Cunningham, A.A., Donald, P.F., Prakash, N., Verma, A., Gargi, R., Sivakumar, S., Rahmani, A.R., Catastrophic collapse of Indian white-backed Gyps bengalensis and long-billed Gyps indicus vulture populations. Biol. Conserv. 109 (2003), 381–390.
96. Prakash, V., Bishwakarma, M.C., Chaudhary, A., Cuthbert, R., Dave, R., Kulkarni, M., Kumar, S., Paudel, K., Ranade, S., Shringarpure, R., Green, R.E., The population decline of Gyps vultures in India and Nepal has slowed since veterinary use of diclofenac was banned. PLoS One, 7, 2012, e49118.
97. Qin, M., Yang, H., Photochemical characteristics of diclofenac and its photodegradation of inclusion complexes with β-cyclodextrins. Quim Nova 35 (2012), 559–562.
98. Rabiet, M., Togola, A., Brissaud, F., Seidel, J.-L., Budzinski, H., Elbaz-Poulichet, F., Consequences of treated water recycling as regards pharmaceuticals and drugs in surface and ground waters of a medium-sized Mediterranean catchment. Environ. Sci. Technol. 40 (2006), 5282–5288.
99. Refat, M.S., Mohamed, G.G., Ibrahim, M.Y.S., Killa, H.M.A., Fetooh, H., Synthesis and characterization of coordination behavior of diclofenac sodium drug toward Hg(II), Pb(II), and Sn(II) metal ions: chelation effect on their thermal stability and biological activity. Synth. React. Inorg., Met.-Org., Nano-Met. Chem. 44 (2014), 161–170.
100. Sacher, F., Lange, F.T., Brauch, H.-J., Blankenhorn, I., Pharmaceuticals in groundwaters: analytical methods and results of a monitoring program in Baden-Württemberg, Germany. J. Chromatogr. A 938 (2001), 199–210.
101. Samaras, V.G., Stasinakis, A.S., Mamais, D., Thomaidis, N.S., Lekkas, T.D., Fate of selected pharmaceuticals and synthetic endocrine disrupting compounds during wastewater treatment and sludge anaerobic digestion. J. Hazard. Mater. 244–245 (2013), 259–267.
102. Scheurell, M., Franke, S., Shah, R.M., Huhnerfuss, H., Occurrence of diclofenac and its metabolites in surface water and effluent samples from Karachi, Pakistan. Chemosphere 77 (2009), 870–876.
103. Scheytt, T., Mersmann, P., Lindstadt, R., Heberer, T., Determination of sorption coefficients of pharmaceutically active substances carbamazepine, diclofenac, and ibuprofen, in sandy sediments. Chemosphere 60 (2005), 245–253.
104. Schmidt, W., O'Rourke, K., Hernan, R., Quinn, B., Effects of the pharmaceuticals gemfibrozil and diclofenac on the marine mussel (Mytilus spp.) and their comparison with standardized toxicity tests. Mar. Pollut. Bull. 62 (2011), 1389–1395.
105. Schmitt-Jansen, M., Bartels, P., Adler, N., Altenburger, R., Phytotoxicity assessment of diclofenac and its phototransformation products. Anal. Bioanal. Chem. 387 (2007), 1389–1396.
106. Schulze, T., Weiss, S., Schymanski, E., von der Ohe, P.C., Schmitt-Jansen, M., Altenburger, R., Streck, G., Brack, W., Identification of a phytotoxic photo-transformation product of diclofenac using effect-directed analysis. Environ. Pollut. 158 (2010), 1461–1466.
107. Schwaiger, J., Ferling, H., Mallow, U., Wintermayr, H., Negele, R.D., Toxic effects of the non-steroidal anti-inflammatory drug diclofenac. Part I: histopathological alterations and bioaccumulation in rainbow trout. Aquat. Toxicol. 68 (2004), 141–150.
108. Sharma, A.K., Saini, M., Singh, S.D., Prakash, V., Das, A., Bharathi Dasan, R., Pandey, S., Bohara, D., Galligan, T.H., Green, R.E., Knopp, D., Cuthbert, R.J., Diclofenac is toxic to the Steppe Eagle Aquila nipalensis: widening the diversity of raptors threatened by NSAID misuse in South Asia. Bird Conserv. Int., 2014, 1–5.
109. Sosiak, A.l., Hebben, T., A.l., S., T., H., (eds.) A Preliminary Survey of Pharmaceuticals and Endocrine Disrupting Compounds in Treated Municipal Wastewaters and Receiving Rivers of Alberta, 2005, Monitoring and Evaluation Branch Environmental Assurance, Alberta.
110. Sotelo, J.L., Rodríguez, A., Álvarez, S., García, J., Removal of caffeine and diclofenac on activated carbon in fixed bed column. Chem. Eng. Res. Des. 90 (2012), 967–974.
111. Sotelo, J.L., Ovejero, G., Rodríguez, A., Álvarez, S., Galán, J., García, J., Competitive adsorption studies of caffeine and diclofenac aqueous solutions by activated carbon. Chem. Eng. J. 240 (2014), 443–453.
112. Stierlin, H., Faigle, J.W., Sallmann, A., Kung, W., Richter, W.J., Kriemler, H.P., Alt, K.O., Winkler, T., Biotransformation of diclofenac sodium (Voltaren®) in animals and in man. Xenobiotica 9 (1979), 601–610.
113. Strenn, B., Clara, M., Gans, O., Kreuzinger, N., Carbamazepine, diclofenac, ibuprofen and bezafibrate - investigations on the behaviour of selected pharmaceuticals during wastewater treatment. Water Sci. Technol. 50 (2004), 269–276.
114. Stulten, D., Lamshoft, M., Zuhlke, S., Spiteller, M., Isolation and characterization of a new human urinary metabolite of diclofenac applying LC–NMR–MS and high-resolution mass analyses. J. Pharm. Biomed. Anal. 47 (2008), 371–376.
115. Stulten, D., Zuhlke, S., Lamshoft, M., Spiteller, M., Occurrence of diclofenac and selected metabolites in sewage effluents. Sci. Total Environ. 405 (2008), 310–316.
116. Suriyanon, N., Punyapalakul, P., Ngamcharussrivichai, C., Mechanistic study of diclofenac and carbamazepine adsorption on functionalized silica-based porous materials. Chem. Eng. J. 214 (2013), 208–218.
117. Swan, G.E., Cuthbert, R., Quevedo, M., Green, R.E., Pain, D.J., Bartels, P., Cunningham, A.A., Duncan, N., Meharg, A.A., Oaks, J.L., Parry-Jones, J., Shultz, S., Taggart, M.A., Verdoorn, G., Wolter, K., Toxicity of diclofenac to Gyps vultures. Biol. Lett. 2 (2006), 279–282.
118. Taggart, M.A., Cuthbert, R., Das, D., Sashikumar, C., Pain, D.J., Green, R.E., Feltrer, Y., Shultz, S., Cunningham, A.A., Meharg, A.A., Diclofenac disposition in Indian cow and goat with reference to Gyps vulture population declines. Environ. Pollut. 147 (2007), 60–65.
119. Taggart, M.A., Senacha, K.R., Green, R.E., Jhala, Y.V., Raghavan, B., Rahmani, A.R., Cuthbert, R., Pain, D.J., Meharg, A.A., Diclofenac residues in carcasses of domestic ungulates available to vultures in India. Environ. Int. 33 (2007), 759–765.
120. Tavares, J., Diclofenac in Europe – current situation, legal aspects, potential impacts and required actions. Technical Dossier. Switzerland: http://www.4vultures.org, 2014.
121. Tavares, J., Diclofenac: Drug Causing Wildlife Catastrophe in South Asia Is Available on EU Market. 2014, Brussels, Vulture Conservation Foundation.
122. The Drug controller General, I. Diclofenac for veterinary use: regarding. Services D.G.o.H., 2006 FNo18-03/2006-DC. New Delhi.
123. Theodorou, A., Demertzis, M.A., Kovala-Demertzi, D., Lioliou, E.E., Pantazaki, A.A., Kyriakidis, D.A., Copper(II) complexes of diclofenac: spectroscopic studies and DNA strand breakage. Biometals 12 (1999), 167–172.
124. Thomas, K.V., Hilton, M.J., The occurrence of selected human pharmaceutical compounds in UK estuaries. Mar. Pollut. Bull. 49 (2004), 436–444.
125. Triebskorn, R., Casper, H., Heyd, A., Eikemper, R., Kohler, H.R., Schwaiger, J., Toxic effects of the non-steroidal anti-inflammatory drug diclofenac. Part II: cytological effects in liver, kidney, gills and intestine of rainbow trout (Oncorhynchus mykiss). Aquat. Toxicol. 68 (2004), 151–166.
126. Valdés, M.E., Amé, M.V., Bistoni, M.d.l.A., Wunderlin, D.A., Occurrence and bioaccumulation of pharmaceuticals in a fish species inhabiting the Suquía River basin (Córdoba, Argentina). Sci. Total Environ. 472 (2014), 389–396.
127. Venkateshwarlu, K., Drug Being Purchased by Farmers illegally to Treat Their Cattle: Study. The Hindu. 2011, The Hindu, Hyderabad.
128. Verlicchi, P., Zambello, E., Pharmaceuticals and personal care products in untreated and treated sewage sludge: occurrence and environmental risk in the case of application on soil — a critical review. Sci. Total Environ. 538 (2015), 750–767.
129. Vieno, N., Sillanpää, M., Fate of diclofenac in municipal wastewater treatment plant — a review. Environ. Int. 69 (2014), 28–39.
130. Virani, M.Z., Kendall, C., Njoroge, P., Thomsett, S., Major declines in the abundance of vultures and other scavenging raptors in and around the Masai Mara ecosystem, Kenya. Biol. Conserv. 144 (2011), 746–752.
131. Weigel, S., Kuhlmann, J., Hühnerfuss, H., Drugs and personal care products as ubiquitous pollutants: occurrence and distribution of clofibric acid, caffeine and DEET in the North Sea. Sci. Total Environ. 295 (2002), 131–141.
132. Willis, J.V., Kendall, M.J., Flinn, R.M., Thornhill, D.P., Welling, P.G., The pharmacokinetics of diclofenac sodium following intravenous and oral administration. Eur. J. Clin. Pharmacol. 16 (1979), 405–410.
133. Xu, J., Wu, L., Chang, A.C., Degradation and adsorption of selected pharmaceuticals and personal care products (PPCPs) in agricultural soils. Chemosphere 77 (2009), 1299–1305.
134. Yamada, T., Kuroda, Y., Fukuoka, A., Ichikawa, M., Tanaka, K., Reactivity of surface hydroxyl groups with metal complex compounds. J. Electron Spectrosc. Relat. Phenom. 54–55 (1990), 845–854.
135. Yoon, Y., Ryu, J., Oh, J., Choi, B.-G., Snyder, S.A., Occurrence of endocrine disrupting compounds, pharmaceuticals, and personal care products in the Han River (Seoul, South Korea). Sci. Total Environ. 408 (2010), 636–643.
136. Zhang, Y., Geissen, S.U., Gal, C., Carbamazepine and diclofenac: removal in wastewater treatment plants and occurrence in water bodies. Chemosphere 73 (2008), 1151–1161.
137. Ziółkowska, A., Piotrowicz-Cieślak, A.I., Rydzyński, D., Adomas, B., Nałęcz-Jawecki, G., Biomarkers of leguminous plant viability in response to soil contamination with diclofenac. Pol. J. Environ. Stud. 23 (2014), 263–269.
138. Zorita, S., Martensson, L., Mathiasson, L., Occurrence and removal of pharmaceuticals in a municipal sewage treatment system in the south of Sweden. Sci. Total Environ. 407 (2009), 2760–2770.